The FDA has granted tentative approval for Basaglar (insulin glargine injection), produced by Eli Lilly and Boehringer Ingelheim's (BI) diabetes alliance, following litigation filed by Sanofi ...
16d
Eli Lilly and Company (NYSE:LLY – Free Report) had its price target reduced by Wells Fargo & Company from $1,000.00 to $970.00 in a research note released on Tuesday,Benzinga reports. They currently ...
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its target price lowered by equities researchers at Citigroup from $1,250.00 to $1,190.00 in a research note issued to investors on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback